Yüklüyor......
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Genetic alterations and epigenetic dysregulation in cancer cells create a vast array of neoepitopes potentially recognizable by the immune system. Immune checkpoint blockade has the capacity to enhance and sustain endogenous immunity against non-mutated tumor-associated antigens as well as uniquely...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319479/ https://ncbi.nlm.nih.gov/pubmed/22236695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2011.12.009 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|